$NTIC

Northern Technologies International Corporation Reports Financial Results for Third Quarter Fiscal 2026

Northern Technologies International (NASDAQ: NTIC) reported third-quarter fiscal 2026 results. Consolidated net sales rose 12.6% to $24.216M, with ZERUST industrial up 10.3% and ZERUST oil and gas up 72.3%. Gross margin fell to 33.6% (down 477 bps). NTIC posted a $263k net loss ($0.03/share) versus net income a year earlier. The company cited higher raw material costs and pricing pressure.

Original reporting
Published Jul 9, 2026, 12:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 9, 2026, 1:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Northern Technologies International Corporation Reports Financial Results for Third Quarter Fiscal 2026 — source image
Decision brief

The 30-second read

$NTICNeutralMed
01

Why it matters

Q3 shows strong top-line momentum (record sales, especially ZERUST oil and gas) but profitability deterioration (gross margin down 477 bps, GAAP net loss). Management expects improving gross margin and profitability in Q4 as raw-material costs ease and pricing/procurement initiatives take effect.

02

Market read

Traders will likely reprice NTIC around margin trajectory and the credibility/timing of management’s Q4 gross margin improvement plan.

03

What to watch

The pending sale of the Beachwood, Ohio facility (expected to close in fiscal 2027) and increased ZERUST oil and gas sales could shift segment mix and profitability beyond what the quarter’s gross margin alone suggests.

Relevance 7/10Novelty 7/10Timing: after-hours/market reaction to Q3 FY2026 results and Q4 margin outlook

Background

NTIC develops corrosion inhibiting products (ZERUST) and Natur-Tec bioplastic resin compounds, and reports both consolidated results and joint-venture activity.

Company-level read

Ticker impact

$NTICNeutralHigh confidence
Context

NTIC reported Q3 FY2026 results with record net sales of $24.216M, but gross margin fell 477 bps and it posted a net loss.

Expected impact

Near-term bias likely mixed, with traders focusing on whether Q4 gross margin can rebound as raw-material costs ease.

Evidence & confidence

The release provides concrete quarterly datapoints (sales, gross margin, net loss) and a specific management expectation for improved profitability in Q4 tied to easing costs and pricing/procurement initiatives.

Market effects

Highlights demand resilience in corrosion prevention and bioplastic solutions, but also shows commodity/raw-material and competitive pricing pressure affecting margins.

No specific regional demand or regulatory driver beyond Middle East-related raw-material cost impacts.

Management cites Middle East conflict and Strait of Hormuz disruptions as a cost driver, linking global geopolitics to input costs and margins.

Counterpoint

The gross margin decline may be temporary if raw-material costs truly ease, making the revenue growth and joint-venture income trend more important than the single-quarter margin miss.

Key entities

  • Northern Technologies International Corporation

    NASDAQ-listed corrosion prevention and bioplastic resin solutions provider reporting Q3 FY2026 financial results.

  • ZERUST

    Corrosion prevention product line; industrial and oil and gas net sales grew to record levels in Q3.

  • Natur-Tec

    Bioplastic product line; net sales rose but gross margin was pressured by competitive pricing.

  • Beachwood, Ohio facility

    Facility reclassified as held for sale; pending sale LOI for $1.15M expected to close in fiscal 2027.

Related articles

$NTICMed

NORTHERN TECHNOLOGIES INTERNATIONAL CORP (NTIC): Results of Operations and Financial Condition

NORTHERN TECHNOLOGIES INTERNATIONAL CORP (NTIC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 Northern Technologies International Corporation Reports Financial Results for Third Quarter Fiscal 2026 MINNEAPOLIS, July 09, 2026 (GLOBE NEWSWIRE) -- Northern Technologies International Corporation (NASDAQ: NTIC), a le

$PSXMed

Phillips 66 Q2 Earnings Call Highlights

Phillips 66 (PSX) said it repaid all outstanding commercial paper and $1 billion of its March 2027 term loan during Q2, with the remaining $1.25 billion repaid in July. It ended the quarter with $4.1B cash and $10.5B committed liquidity. Management guided Q3 refining capture near 95% and midstream EBITDA run rate to $4.5B by end-2027.

$PSBDMed

Palmer Square Capital BDC Q2 Earnings Call Highlights

Palmer Square Capital BDC (PSBD) reported Q2 NAV per share of $13.21, down from $13.30, citing fair-value adjustments tied to broadly syndicated loan pricing. Portfolio fair value was about $1.11B. It made 21 commitments totaling $72.4M and realized $109.8M from repayments and sales. Management expanded buybacks and reset a BDC CLO to lower debt cost.

$QSRMed

Restaurant Brands International Q2 Earnings Call Highlights

Restaurant Brands International (QSR) reported Q2 call highlights including Burger King average unit volumes up more than 20% since its elevation campaign, and Kids Meal volumes up nearly 50% vs 2022. International delivered 5.5% comparable-sales growth. Free cash flow was $501 million, with $137 million stock repurchases and guidance for 2026 refranchising. Liquidity was about $2.3 billion.

$RBAMed

RB Global Q2 Earnings Call Highlights

RB Global (NYSE:RBA) reported Q2 call highlights on integration of BigIron and segment performance. Management said BigIron’s financial impact will be reflected later in the year. Automotive GTV rose 13% and heavy equipment/transportation GTV rose 8%. Service revenue grew 5% with take rate down 110 bps to 20%. Full-year 2026 GTV guidance raised to 9% to 11%, with adjusted EBITDA growth ~8.6% midpoint; dividend increased and CAD 150M buyback reported.

$QGENMedAI 8/10

Qiagen Q2 Earnings Call Highlights

QIAGEN reported Q2 genomics and NGS sales up 2% at constant exchange rates, with QIAGEN Digital Insights growing single digits and universal NGS panel consumables for third-party sequencers rising over 20%. Adjusted operating income fell 2% to $157M, margin 29.4%. Operating cash flow was $301M for 1H. QGEN reaffirmed FY sales growth of ~1% to 2% and adjusted diluted EPS at least $2.43.